Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07184970

PRISM Study: Prostate Recurrence Detection Using Imaging With PSMA PET/MRI Post-high Intensity Focused Ultrasound

Prostate Recurrence Detection Using Imaging With PSMA PET/MRI Post-high Intensity Focused Ultrasound

Status
Recruiting
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
NYU Langone Health · Academic / Other
Sex
Male
Age
40 Years – 95 Years
Healthy volunteers

Summary

The purpose of this study is to compare the sensitivity of PSMA PET/MRI and standard MRI in detecting focal therapy failure in the prostate one year after High-Intensity Focused Ultrasound (HIFU) treatment. Specifically, the study aims to evaluate whether PSMA PET/MRI offers a higher sensitivity than MRI alone for identifying recurrence or failure in patients undergoing focal therapy.

Conditions

Timeline

Start date
2025-10-08
Primary completion
2027-10-01
Completion
2028-10-01
First posted
2025-09-22
Last updated
2025-10-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07184970. Inclusion in this directory is not an endorsement.